Table 1.
Variable, units of measurement | Total number of subjects | Pre-roflumilast, mean (SE) | Post-roflumilast, mean (SE) | P-value |
---|---|---|---|---|
Fasting plasma glucose, mg/dL | 7 | 100.7 (3.4) | 100.5 (2.7) | 0.94* |
Fasting plasma insulin, mcU/mL | 6 | 20.6 (7.9) | 27.3 (13.4) | 0.46* |
Basal hepatic glucose production, mg/kg lean mass/minute | 7 | 2.45 (0.13) | 2.78 (0.22) | 0.10 |
Hepatic insulin resistance index | 6 | 47.7 (15.7) | 68.4 (27.7) | 0.35* |
Mean M value, mg/g fat free mass/minute | 7 | 48.7 (10.4) | 70.0 (20.1) | 0.18* |
Notes:
P-value as determined using Related Samples-Wilcoxon Signed Rank Test. All other P-values are from paired t-test analysis.